{"id":"W2141303400","doi":"10.1093/annonc/mdu517","title":"Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Erlotinib; Medicine; Erlotinib Hydrochloride; Internal medicine; Lung cancer; Hazard ratio; Clinical endpoint; Oncology; Regimen; Randomized controlled trial; Adverse effect; Phases of clinical research; Gastroenterology; Clinical trial; Epidermal growth factor receptor; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003925995,0.0001652525,0.001015982,0.0002708783,0.00002002838,0.000003416374,0.0000748016,0.0001079795,0.00006175006],"category_scores_gemma":[0.00009567317,0.000117668,0.00007343576,0.0002779637,0.0001662628,0.00008991148,0.00001690327,0.0001374039,0.000001154744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001263012,"about_ca_system_score_gemma":0.0005864966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001536504,"about_ca_topic_score_gemma":0.001243635,"domain_scores_codex":[0.9984905,0.0001871843,0.0005783366,0.0002440871,0.0002581867,0.0002417543],"domain_scores_gemma":[0.998513,0.000424953,0.0004577349,0.0001966811,0.0003294568,0.00007810874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9526064,0.00712357,0.02900006,0.0001017601,0.000319934,0.000014614,0.001441217,0.00009124186,0.00001800247,0.000190495,0.0001891525,0.008903541],"study_design_scores_gemma":[0.9604019,0.0211486,0.01641297,0.0001749308,0.0004379797,0.000001080882,0.00009840282,0.0003399334,0.0004987788,0.00001979744,0.0003551063,0.0001105065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898784,0.0001866365,0.00005795777,0.0009797136,0.0001914229,0.00284072,0.00002773174,0.000009025134,0.00582843],"genre_scores_gemma":[0.9988211,0.0000677794,0.0002723143,0.0001737591,0.00003993821,0.0003418926,0.0001365798,0.00002003916,0.0001265789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01402503,"threshold_uncertainty_score":0.4798363,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03339481456787664,"score_gpt":0.3862463530074766,"score_spread":0.3528515384395999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}